This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Metabolism and Angiogenesis
joint with Tumor Metabolism
Organizer(s): Peter F. Carmeliet and Michael Simons
Date: March 16 - 21, 2014
Location: Whistler Conference Centre, Whistler, BC, Canada
Supported by the Directors' Fund
Summary of Meeting:
Endothelial cells are required to be quiescent in healthy conditions while having the capacity to actively proliferate and migrate during angiogenic sprouting. The transition from quiescence to rapid proliferation requires metabolic reprogramming that is very similar to that seen in rapidly growing tumor cells. Therefore, the integration of the fields of angiogenesis, metabolism and cancer biology has become a very hot topic in biomedical research. Since blood vessels arose in evolution to deliver nutrients and oxygen, it is not surprising that angiogenesis and metabolism are closely linked. The interface of these fields also offers unprecedented opportunities for pro- and anti-angiogenic therapies. This Keystone Symposia meeting on Metabolism and Angiogenesis will enhance cross-talk between researchers in the fields of angiogenesis (vascular biology) and cellular metabolism with a view of understanding the underlying biology and for identifying opportunities for new therapeutic strategies. Opportunities for cross-fertilization of ideas and interdisciplinary interactions will be further strengthened by joint keynote and plenary sessions with the concurrent meeting on “Tumor Metabolism.”
Scholarship Deadline: November 18 2013
Discounted Abstract Deadline: November 18 2013
Abstract Deadline: December 17 2013
Discounted Registration Deadline: January 15 2014
We gratefully acknowledge additional support for this conference from:
Promega Corporation
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Regeneron Pharmaceuticals, Inc.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
EMBO (European Molecular Biology Organization)
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA183117-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found